Orange Book product · Generic (ANDA)
LEVOCETIRIZINE DIHYDROCHLORIDE
LEVOCETIRIZINE DIHYDROCHLORIDE
At a glance
May 15, 2017
Approved
Generic (ANDA)
Application
AA
TE code
None
Listed patents
Key dates
Approval
FDA approval date of this drug product.
May 15, 2017
9 yr 3 mo ago
Today
Pharmaceutical detail
Active ingredient
LEVOCETIRIZINE DIHYDROCHLORIDE
Strength
2.5MG/5ML
Dosage form
SOLUTION
Route
ORAL
TE code
AA
Application
ANDA 204599
Product number
001
Marketing status
RX
Reference listed drug (RLD)
No
Reference standard (RS)
No
Active-ingredient family
View full familyGeneric (ANDA) of LEVOCETIRIZINE DIHYDROCHLORIDE
- 2017XYZAL ALLERGY 24HRBrand (NDA)
NDA 209090 · CHATTEM SANOFI
- 2017XYZAL ALLERGY 24HRBrand (NDA)
NDA 209089 · CHATTEM SANOFI
- 2008XYZALBrand (NDA)
NDA 022157 · CHATTEM SANOFI
- 2007XYZALBrand (NDA)
NDA 022064 · CHATTEM SANOFI
- 2024LEVOCETIRIZINE DIHYDROCHLORIDEGeneric (ANDA)
ANDA 204626 · IPCA LABS LTD
- 2021LEVOCETIRIZINE DIHYDROCHLORIDEGeneric (ANDA)
ANDA 211443 · APOTEX
- 2020LEVOCETIRIZINE DIHYDROCHLORIDEGeneric (ANDA)
ANDA 213513 · HETERO LABS LTD III
- 2019LEVOCETIRIZINE HYDROCHLORIDEGeneric (ANDA)
ANDA 210914 · HETERO LABS LTD III
- 2019LEVOCETIRIZINE DIHYDROCHLORIDEGeneric (ANDA)
ANDA 211983 · PERRIGO R AND D
- 2018LEVOCETIRIZINE DIHYDROCHLORIDEGeneric (ANDA)
ANDA 211551 · SANKALP LIFECARE
- 2018LEVOCETIRIZINE DIHYDROCHLORIDEGeneric (ANDA)
ANDA 210375 · DR REDDYS
- 2016LEVOCETIRIZINE DIHYDROCHLORIDEGeneric (ANDA)
ANDA 204323 · US ANTIBIOTICS
Listed patents
No patents are listed against this product in the Orange Book. Listed patents reflect those the NDA holder submits under 21 U.S.C. 355 and are not exhaustive.
